| CASE REPORT |
|
| Year : 2022 | Volume
: 11
| Issue : 2 | Page : 115-119 |
|
|
A rare occurrence of tumoural calcinosis of long head biceps tendon post-COVID-19 infection
Mohamad Azwan Aziz1, Harmizie Osman2, Mohanakumar Kalimuthu2, Rozaiman Ebrahim2
1 Department of Sports Medicine, University Malaya Medical Centre; Sports Medicine Unit, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia
2 Department of Orthopedic, Sports Medicine Unit, Hospital Tuanku Jaafar, Seremban, Malaysia
Correspondence Address:
Mohamad Azwan Aziz
Department of Sports Medicine, University Malaya Medical Centre; Sports Medicine Unit, Faculty of Medicine, University of Malaya, Kuala Lumpur
Malaysia
 Source of Support: None, Conflict of Interest: None
DOI: 10.4103/mohe.mohe_28_22
|
|
|
Tumoural calcinosis is a rare entity commonly caused by hyperphosphatemia due to bone mineral disease, hyperparathyroidism of chronic renal failure. However, our case demonstrated a normo-phosphatemic tumoural calcinosis post-COVID-19. This is a 36-year-old with a multiple history of soft-tissue calcification presented with acute onset severe right shoulder pain associated with anterior shoulder swelling at day 20 post-COVID-19. The clinical examination reveals anterior shoulder swelling at bicipital groove with severe restriction of range of motion due to pain. Ultrasound revealed an initial solid mass arising from the sheath of long head of biceps tendon which turns into cystic mass at week 4 of the disease. Computed tomography scan demonstrate sedimentation sign. His blood parameters revealed normo-calcemic, normo-phosphatemic bone profile, normal renal function and no sign suggestive of rheumatological disease. He was started on short course on non-steroidal anti-inflammatory drugs (NSAIDs) for 3 week and does not require surgical intervention. His symptoms completely resolved after 4 weeks with persistent shoulder swelling. He was started with prophylaxis low phosphate diet to prevent future recurrence. Our case demonstrates that conservative management using the short course of NSAIDs can be beneficial in treating primary normophosphatemic tumoural calcinosis.
|
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
Next article
